Alpha1-acid glycoprotein concentration and serum protein binding of carbamazepine and carbamazepine-10,11 epoxide in children with epilepsy

M. Contin, R. Riva, F. Albani, E. Perucca, G. Lamontanara, A. Baruzzi

Research output: Contribution to journalArticlepeer-review

Abstract

The relationship between the serum protein binding of carbamazepine (CBZ) and carbamazepine-10,11 epoxide (CBZ-E) and the concentration of α1-acid glycoprotein (AAG) and albumin (HSA) was examined in 39 CBZ-treated epileptic children aged 4 months to 12 years. A significant inverse correlation was found between the free fraction of both compounds and serum AAG, even though changes in AAG concentration explained only part of the variation in binding. No correlation was found between the free fraction of CBZ and CBZ-E and HSA, probably due to the small intersubject variation in HSA concentration. In vitro experiments showed that both CBZ and CBZ-E were bound to HSA and to a lesser extent to AAG. At equivalent HSA concentrations, the binding of CBZ and its metabolite increased proportionately with increasing AAG concentration within the range occurring clinically.

Original languageEnglish
Pages (from-to)211-214
Number of pages4
JournalEuropean Journal of Clinical Pharmacology
Volume29
Issue number2
DOIs
Publication statusPublished - Mar 1985

Keywords

  • alpha-acid glycoprotein
  • carbamazepine
  • carbamazepine-10,11 epoxide
  • children
  • epilepsy
  • serum protein binding

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Alpha1-acid glycoprotein concentration and serum protein binding of carbamazepine and carbamazepine-10,11 epoxide in children with epilepsy'. Together they form a unique fingerprint.

Cite this